Project was a Demand Study for a pipeline agent (Product X) in Phase 3 clinical trials to treat major depressive disorder (MDD).
Brand X, a diagnostics company, partnered to conduct a marketing research program (awareness, trial and utilization - ATU) to monitor the launch of their new platform, Product X.
Client requested an analysis of ophthalmology patient data captured from nearly 200 retina specialists who submitted all of their patient interaction information via Electronic Medical Record (EMR) transfer, every month, for over four years.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.